<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2679665-A1" country="EP" doc-number="2679665" kind="A1" date="20140101" family-id="44167752" file-reference-id="305536" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146549827" ucid="EP-2679665-A1"><document-id><country>EP</country><doc-number>2679665</doc-number><kind>A1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-13185874-A" is-representative="NO"><document-id mxw-id="PAPP154823750" load-source="docdb" format="epo"><country>EP</country><doc-number>13185874</doc-number><kind>A</kind><date>20101215</date><lang>EN</lang></document-id><document-id mxw-id="PAPP181443902" load-source="docdb" format="original"><country>EP</country><doc-number>13185874.8</doc-number><date>20101215</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140451633" ucid="EP-09179465-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>09179465</doc-number><kind>A</kind><date>20091216</date></document-id></priority-claim><priority-claim mxw-id="PPC140449386" ucid="EP-10794976-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>10794976</doc-number><kind>A</kind><date>20101215</date></document-id></priority-claim><priority-claim mxw-id="PPC140448184" ucid="EP-13185874-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>13185874</doc-number><kind>A</kind><date>20101215</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988111130" load-source="docdb">C12N   5/00        20060101ALI20131122BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988122279" load-source="docdb">C12M   3/00        20060101AFI20131122BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1946289568" load-source="docdb" scheme="CPC">C12N2537/00        20130101 LA20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289569" load-source="docdb" scheme="CPC">C12N2535/00        20130101 LA20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289570" load-source="docdb" scheme="CPC">C12N2533/30        20130101 LA20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289571" load-source="docdb" scheme="CPC">C12N   5/0062      20130101 FI20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289572" load-source="docdb" scheme="CPC">C12M  21/08        20130101 LI20160423BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289573" load-source="docdb" scheme="CPC">B33Y  50/02        20141201 LA20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1946289574" load-source="docdb" scheme="CPC">B33Y  10/00        20141201 LA20160421BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957302749" load-source="docdb" scheme="CPC">A61L  27/50        20130101 LI20160324BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957302853" load-source="docdb" scheme="CPC">A61K  35/32        20130101 LI20160325BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957304304" load-source="docdb" scheme="CPC">A61L  27/18        20130101 LI20160324BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957306231" load-source="docdb" scheme="CPC">A61L  27/56        20130101 LI20160324BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957307374" load-source="docdb" scheme="CPC">A61L2300/64        20130101 LA20160324BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1957309036" load-source="docdb" scheme="CPC">C12M  23/02        20130101 LI20160324BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2029358751" load-source="docdb" scheme="CPC">C12M  25/14        20130101 LI20150815BHEP        </classification-cpc><classification-cpc mxw-id="PCL2091570229" load-source="docdb" scheme="CPC">A61K   9/00        20130101 LI20140626BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132181965" lang="DE" load-source="patent-office">Ger√ºst zum Gewebewachstum in vivo</invention-title><invention-title mxw-id="PT132181966" lang="EN" load-source="patent-office">Scaffold for the growth of tissue in vivo</invention-title><invention-title mxw-id="PT132181967" lang="FR" load-source="patent-office">Support pour la coissance de tissus in vivo</invention-title><citations><patent-citations><patcit mxw-id="PCIT242653660" load-source="docdb" ucid="US-20090186412-A1"><document-id format="epo"><country>US</country><doc-number>20090186412</doc-number><kind>A1</kind><date>20090723</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242653656" load-source="docdb" ucid="US-6194210-B1"><document-id format="epo"><country>US</country><doc-number>6194210</doc-number><kind>B1</kind><date>20010227</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242653657" load-source="docdb" ucid="US-6218182-B1"><document-id format="epo"><country>US</country><doc-number>6218182</doc-number><kind>B1</kind><date>20010417</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT377696280" load-source="docdb" ucid="US-6283997-B1"><document-id format="epo"><country>US</country><doc-number>6283997</doc-number><kind>B1</kind><date>20010904</date></document-id><sources><source name="SEA" category="XI" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT377696281" load-source="docdb" ucid="WO-2005012504-A1"><document-id format="epo"><country>WO</country><doc-number>2005012504</doc-number><kind>A1</kind><date>20050210</date></document-id><sources><source name="SEA" category="XI" created-by-npl="N"/></sources></patcit></patent-citations></citations></technical-data><related-documents><relation type="division"><child-doc ucid="EP-13185874-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>13185874</doc-number><kind>A</kind><date>20101215</date></document-id></child-doc><parent-doc ucid="EP-10794976.0"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>10794976.0</doc-number><date>20101215</date></document-id><parent-grant-document ucid="EP-2513288-B1"><document-id><country>EP</country><doc-number>2513288</doc-number><kind>B1</kind><date>20140319</date></document-id></parent-grant-document></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR918152527" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>VIVABIOCELL SPA</last-name><address><country>IT</country></address></addressbook></applicant><applicant mxw-id="PPAR918133048" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>VIVABIOCELL SPA</last-name></addressbook></applicant><applicant mxw-id="PPAR918988853" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>VivaBioCell SpA</last-name><iid>101330370</iid><address><street>Via del Cotonifico 127</street><city>33100 Udine</city><country>IT</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918155924" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>CURCIO FRANCESCO</last-name><address><country>IT</country></address></addressbook></inventor><inventor mxw-id="PPAR918152614" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>CURCIO, FRANCESCO</last-name></addressbook></inventor><inventor mxw-id="PPAR918990514" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>CURCIO, FRANCESCO</last-name><address><street>via del Cormor 7</street><city>33010 Pagnacco (Udine)</city><country>IT</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR918987585" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Longoni, Alessandra</last-name><iid>101232783</iid><address><street>AL &amp; Partners Srl Via C. Colombo ang. Via Appiani (Corte del Colone)</street><city>20831 Seregno (MB)</city><country>IT</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548885436" load-source="docdb">AL</country><country mxw-id="DS548848780" load-source="docdb">AT</country><country mxw-id="DS548885437" load-source="docdb">BE</country><country mxw-id="DS548902857" load-source="docdb">BG</country><country mxw-id="DS548897868" load-source="docdb">CH</country><country mxw-id="DS548885438" load-source="docdb">CY</country><country mxw-id="DS548807440" load-source="docdb">CZ</country><country mxw-id="DS548892400" load-source="docdb">DE</country><country mxw-id="DS548885439" load-source="docdb">DK</country><country mxw-id="DS548885440" load-source="docdb">EE</country><country mxw-id="DS548812556" load-source="docdb">ES</country><country mxw-id="DS548902858" load-source="docdb">FI</country><country mxw-id="DS548902859" load-source="docdb">FR</country><country mxw-id="DS548892401" load-source="docdb">GB</country><country mxw-id="DS548885441" load-source="docdb">GR</country><country mxw-id="DS548892406" load-source="docdb">HR</country><country mxw-id="DS548807441" load-source="docdb">HU</country><country mxw-id="DS548897869" load-source="docdb">IE</country><country mxw-id="DS548885442" load-source="docdb">IS</country><country mxw-id="DS548902860" load-source="docdb">IT</country><country mxw-id="DS548885443" load-source="docdb">LI</country><country mxw-id="DS548892407" load-source="docdb">LT</country><country mxw-id="DS548848781" load-source="docdb">LU</country><country mxw-id="DS548902861" load-source="docdb">LV</country><country mxw-id="DS548892408" load-source="docdb">MC</country><country mxw-id="DS548848782" load-source="docdb">MK</country><country mxw-id="DS548848783" load-source="docdb">MT</country><country mxw-id="DS548848784" load-source="docdb">NL</country><country mxw-id="DS548897878" load-source="docdb">NO</country><country mxw-id="DS548848785" load-source="docdb">PL</country><country mxw-id="DS548812557" load-source="docdb">PT</country><country mxw-id="DS548889983" load-source="docdb">RO</country><country mxw-id="DS548812558" load-source="docdb">RS</country><country mxw-id="DS548848786" load-source="docdb">SE</country><country mxw-id="DS548892409" load-source="docdb">SI</country><country mxw-id="DS548897879" load-source="docdb">SK</country><country mxw-id="DS548897880" load-source="docdb">SM</country><country mxw-id="DS548885444" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128670496" lang="EN" load-source="patent-office"><p id="pa01" num="0001">A continuous device for culturing mammalian cells in a three-dimensional structure for the transplantation or implantation <i>in vivo</i> is described. The culturing device comprises (a) a scaffold formed by a matrix of interconnected growth surfaces spaced at regular intervals and (b) a fluid distribution means at the inlet and the exit of the growth areas. The device is particularly useful for culturing bone cells for dental implants or bone reconstruction.
<img id="iaf01" file="imgaf001.tif" wi="99" he="107" img-content="drawing" img-format="tif"/></p></abstract><abstract mxw-id="PA128499869" lang="EN" source="EPO" load-source="docdb"><p>A continuous device for culturing mammalian cells in a three-dimensional structure for the transplantation or implantation  in vivo  is described. The culturing device comprises (a) a scaffold formed by a matrix of interconnected growth surfaces spaced at regular intervals and (b) a fluid distribution means at the inlet and the exit of the growth areas. The device is particularly useful for culturing bone cells for dental implants or bone reconstruction.</p></abstract><description mxw-id="PDES63955926" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><p id="p0001" num="0001">The present invention relates to a device for culturing mammalian cells in a three-dimensional structure for the transplantation or implantation <i>in vivo.</i> More particularly, the present invention relates to a continuous culturing device for culturing bone cells for dental implants or bone reconstruction.</p><p id="p0002" num="0002">There is increasing interest in growing cells in three-dimensional (3D) environments such as on a 3D structure or scaffold. Cell culture on 3D scaffolds is useful in tissue engineering for the generation of implantable tissue structures. Intrinsic difficulties with 3D cultures in 3D scaffolds are (i) the uniform and efficient seeding of cells throughout the scaffold pores, and (ii) limited mass transfer to the cells in the central scaffold part.</p><p id="p0003" num="0003">The past three decades have shown great advances in the area of tissue engineering but the problem associated with the difficulty of culturing cells at the center of deep or thick structures remains.</p><p id="p0004" num="0004"><patcit id="pcit0001" dnum="US6194210B"><text>U.S. Patent 6,194,210</text></patcit> describes a process for hepatitis A virus in an aggregated microcarrier-cell culture.</p><p id="p0005" num="0005"><patcit id="pcit0002" dnum="US6218182B"><text>U.S. Patent 6,218,182</text></patcit> describes a method for culturing 3D tissues, in particular liver tissue for use as an extracorporeal liver assist device, in a bioreactor where cells are seeded and provided with two media flows, each contacting a different side of the cells.</p><p id="p0006" num="0006"><patcit id="pcit0003" dnum="US20090186412A"><text>US 2009/0186412</text></patcit> describes a porous cell scaffold and methods for its production. All prior art references address the problems that arise when a culture system with a high density of cells encounters flow irregularities.</p><p id="p0007" num="0007">Known bioreactors do not efficiently simulate <i>in vivo</i> nutrient mechanism in thick structures or when culture density is high.</p><p id="p0008" num="0008">Regulation of flow, delivery of nutrients, gasses and removal of waste in the bodies of mammals is an automated process that encompasses many complex functions in the body. Blood is a complex system, that supports the ability to transport large quantities of gasses and nutrients to and from cells throughout the body. Flow is<!-- EPO <DP n="2"> --> managed by a complex system that automatically alters volume and pressure to redistribute the flow of blood to areas of high demand. The distribution system includes thousands of branches and each branch may have smaller internal diameters until finally arriving at the dimensional level where the cells are nourished. The use of Computational Fluid Dynamics (CFD) software permits analysis of the flow within a complex structure and its container. When a suitable combination of characteristics are identified, the metabolic parameters can be studied to assure that both the utilisation rate of materials and the production of waste products remain in a typically safe zone. One example would be to calculate the maximum cell density and the oxygen consumption rate, to assure that all the cells remain aerobic.</p><p id="p0009" num="0009">We have now found a continuous culture device which solves the problem of culturing cells at the center of deep or thick structures.</p><p id="p0010" num="0010">Object of the present invention is a continuous culture device comprising (a) a scaffold formed by a matrix of interconnected growth surfaces spaced at regular intervals and (b) a fluid distribution means at the inlet and the exit of the growth areas.</p><p id="p0011" num="0011">The spacing and definition are arranged to permit directional flow through and around the growth surfaces uniformly.</p><p id="p0012" num="0012">The fluid distribution means at the inlet and the exit of the growth areas permits an adequate flow to each growth surfaces. The fluid distribution is analysed using computational fluid dynamics and key metabolite utilisation analysis to assure that the cells are not subject to detrimental growth conditions.</p><p id="p0013" num="0013">Preferably, the fluid distribution means distributes the incoming flow of fresh nutrients and gasses to the growth surfaces. The cross-sectional area of the distribution device channels and the number of channels can be adjusted to facilitate the uniform distribution to the growth surfaces, depending on the shape of the growth surfaces and the total number of cells supported by the growth surfaces. Preferably, the culture device includes a matrix of interconnected growth surfaces, defined by the interconnection of multiple fibers or three-dimensional structures, in<!-- EPO <DP n="3"> --> an organized and repetitive manner, which can incorporate any number of facets or surface artefacts utilised to encourage or enhance the attachment and growth of cells.</p><p id="p0014" num="0014">The three-dimensional structures forming the matrix can be cylindrical, rectangular, hexagonal or any other shape or combination of shapes and the surfaces may be smooth or textured.</p><p id="p0015" num="0015">In a practical preferred embodiment of the invention, the scaffold is formed by a matrix of interconnected growth surfaces spaced at regular intervals around a central support.</p><p id="p0016" num="0016">The open spaces formed by the interconnection of the structures, are equal or larger than 0.7 mm and smaller than 3 mm, preferably equal or larger than 0.9 mm and smaller than 3 mm. The spacing in the preferred embodiment is greater than 1.0 mm, but can be altered as required by the need for physical strength of the scaffold. In a still more preferred embodiment of the present invention, the interconnected growth surfaces are spaced at regular intervals equal or larger than 1.0 mm and less than 2.0 mm.</p><p id="p0017" num="0017">Spacing is a characterizing feature of the present invention. The variability of the parameter around the above range allows to optimize the flow of medium throughout the scaffold and, at the same time, to impart an adequate solidity to the 3D structure for all the devices according to the invention independently from their final shape and dimension. The open spaces formed by the interconnecttion of the growth surfaces create the organised characterizing structure of the device of the present invention which differs from the porous structure of the device known from the prior art.</p><p id="p0018" num="0018">The shape of the scaffold is preferably cubic but it could be another shape, for example cylindrical or anatomically correct.</p><p id="p0019" num="0019">Preferably, the culture device includes a large number of interconnected growth surfaces uniformly arranged to create large open areas that limit the maximum number of cells per cubic volume facilitating the easy vascularization of the growth<!-- EPO <DP n="4"> --> areas.</p><p id="p0020" num="0020">The culture device can be made of any biocompatible material.</p><p id="p0021" num="0021">Biocompatible materials are any biocompatible organic polymer or mixture thereof as well as blends or mixtures of biocompatible organic polymers with biocompatible organic or inorganic non-polymeric compounds.</p><p id="p0022" num="0022">Non limitative specific examples of components of the biocompatible material useful in the present invention are polycaprolacton, polyethylene oxide - terephthalate, polyamide, poly-L-lactic acid, polyglycolic acid, collagen, fibronectin, hydroxyapatite, etc.</p><p id="p0023" num="0023">In a practical preferred embodiment, the culture device further comprises an aseptically sealed housing that can be disassembled at the completion of the culture period. Said aseptic housing can include a sealed removable cover, an inlet distribution means, an optional exit distribution means, and the necessary support means required to locate and secure the growth surfaces in the culture device.</p><p id="p0024" num="0024">The housing can be in the form of a rectangle, cylinder or any other shape necessary to hold the culture device and provide additional features for aseptic removal of the scaffold.</p><p id="p0025" num="0025">The present invention offers several advantages over previous culture devices in that nutrient delivery permits the creation of and maintaining the viability of tissue on a thick (&gt; 1 mm) substrate.</p><p id="p0026" num="0026">The 3D culture device of the present invention can be produced in a single step process.</p><p id="p0027" num="0027">Alternatively, a 2D layer can be produced first, and then the single 2D layers can be assembled one over the others to form the 3D culture device according to the present invention.</p><p id="p0028" num="0028">The final dimension of the 3D culture device will depend on the number of assembled 2D layers.</p><p id="p0029" num="0029">The culture device of the present invention can be efficiently used for culturing any kind of cells into a 3D tissue. Preferably it is used for culturing cells for dental<!-- EPO <DP n="5"> --> implants or bone reconstruction. Once the cells have grown into a 3D tissue, the media flow may be stopped and the tissue can be used or preserved for future use. The culture device of the present invention can be efficiently used also for culturing cells directly into the body. In fact, the device can be implanted into the patient in need of tissue reconstruction and the culturing is effected <i>in vivo.</i></p><p id="p0030" num="0030">By using the culture device according to the present invention cells may be grown in a controlled environment on a biodegradable scaffold. The large open areas formed by the interconnection of the growth surfaces allows them to be exposed to a uniform flow of medium and to prevent fouling during the growth process. In particular, fouling or blockade of the growth surface by gas bubbles during the growth process is prevented.</p><p id="p0031" num="0031">Moreover, with the culture device of the invention, culture conditions are monitored continuously and any departures from the desired conditions are automatically corrected and alarmed. This provides conditions necessary to maintain cells in their undifferentiated state, to minimise the maximum cell density and the associated toxic necrosis, and to provide an environment that is not diffusion limited for key nutrients and gasses.</p><p id="p0032" num="0032">Furthermore the culture device according to the present invention provides the growth of tissues also in the absence of cells, as shown in experiments carried out on rabbits.</p><heading id="h0001">EXAMPLE</heading><heading id="h0002"><u>Experimental protocol</u></heading><p id="p0033" num="0033">A two-layer scaffold (11 mm x 11 mm x 5mm) according to the present invention, cut in four pieces of equal dimension, was used for the cell growth experiment on mice.</p><heading id="h0003"><u>Histological analysis and results</u></heading><p id="p0034" num="0034">The four continuous culturing devices were implantated into immunodeficient NOD/SCID mice.</p><p id="p0035" num="0035">The analysis of the inflammatory reaction after one week from the implantation showed no sign of typical inflammatory reaction, i.e. swelling, redness, exudates,<!-- EPO <DP n="6"> --> etc.</p><p id="p0036" num="0036">Histological analysis of the control material HA (Hydroxy Apatite), i.e. a biomedical material commercially available used as standard sample, did not reveal phlogosis (e.g. lymphocytic infiltration) conversely it revealed the integration of the porous ceramic material with the tissues (fibroblast colonization of the material's pores). Poly-capro-lactone was removed from all the samples containing the continuous culturing device object of the present invention and was replaced by paraffin. It resulted in a negative or empty image on microphotographs.</p><p id="p0037" num="0037">Histological analysis of the samples P (Polycaprolactone), PC (Polycaprolactone with cells), PD (Polycaprolactone with tri-calcium phosphate dipping) (<figref idrefs="f0007">Figure 7</figref>), and PDC (Polycaprolactone with tri-calcium phosphate dipping with cells) (<figref idrefs="f0008">Figure 8</figref>) did not reveal any tissue's inflammatory process. Then the implantation in vivo of the continuous culturing device object of the present invention, provided cell growth without involving tissue's inflammation process.</p><p id="p0038" num="0038">The analysis carried out on mice demonstrated that the continuous culturing device is biocompatible and not locally toxic. Moreover the characteristic 3D structure of the continuous culturing device provides the tissue's regrowth.</p><p id="p0039" num="0039">The present invention is now illustrated in more details in the following drawings which represent specific embodiments of the invention without limiting it.</p><heading id="h0004">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p0040" num="0040"><ul><li><figref idrefs="f0001">Fig. 1</figref> One embodiment of the scaffold</li><li><figref idrefs="f0002">Fig. 2</figref> One embodiment of a flow distribution device</li><li><figref idrefs="f0003">Fig. 3</figref> One embodiment of scaffold between two flow distribution devices</li><li><figref idrefs="f0004">Fig. 4</figref> System flow chart</li><li><figref idrefs="f0005">Fig. 5</figref> CFD Flow analysis</li><li><figref idrefs="f0006">Fig. 6</figref> Photographic Flow analysis</li><li><figref idrefs="f0007">Fig. 7</figref> Microphotograph of the sample PD</li><li><figref idrefs="f0008">Fig. 8</figref> Microphotograph of the sample PDC</li><li><figref idrefs="f0009">Fig. 9</figref> Photographs of samples HA, PD and PDC</li></ul><!-- EPO <DP n="7"> --></p><heading id="h0005">DETAILED DESCRIPTION OF THE DRAWINGS</heading><p id="p0041" num="0041"><ul><li><figref idrefs="f0001">Fig. 1</figref> is one embodiment of the scaffold. Scaffold (1) is formed by the interconnection of a matrix of cylindrical (3) structures. The scaffold (1) is formed around the central support (2).</li><li><figref idrefs="f0002">Fig. 2</figref> is one embodiment of the fluid distribution device (5). In this device, the fluid is presented to the device (5) at a common conduit (6) which is connected to the distribution conduits (7). A support means (8) is shown to connect with the central support (2) of the scaffold (1).</li><li><figref idrefs="f0003">Fig. 3</figref> depicts a scaffold (1) positioned between two of the distribution devices (5). In this embodiment the fluid is delivered to the inlet common conduit (6) and further distribute to distribution conduits (7) and then is distributed through and around the open structures (4) of scaffold (1). The fluid is then collected and presented to common conduits (7), located in the outlet device (5B) where it is collected and presented to the common conduit (6) of the distribution device (5B).</li><li><figref idrefs="f0004">Fig. 4</figref> is an outline view of the culture device (10) connected to a central circulation system (9). When the culture device (10) is connected to system (9), it is positioned to receive a continuous flow of nutrients and dissolved gasses provided by pump (12). A central circulation loop is created by connecting the outlet of pump (12) with the inlet of the culture device (10). The outlet of the culture device (10) is connected with the inlet of pump (12) through the fluid reservoir (13). In constant communication with the fluid in the system (12) are a variety of sensors (11). The sensors (11) are connected with a control means (20) that monitors and controls the conditions of system (12). Additional pumps (14, 15) are provided to supply metered delivery of fresh nutrients to the system, and waste materials from the system.</li><li><figref idrefs="f0005">Fig. 5</figref> illustrates an example of Computational Fluid Dynamics analysis, where the distribution of flow is throughout the structure.</li><li><figref idrefs="f0006">Fig. 6</figref> is a photographic flow analysis.</li><li><figref idrefs="f0007">Fig. 7</figref> and <figref idrefs="f0008">Fig. 8</figref> illustrate the growth of cells and the absence of inflammatory<!-- EPO <DP n="8"> --> process for the sample PD and the sample PDC respectively. Microphotographs are 20X of magnification and the cutis are on the top of the microphotographs.</li><li><figref idrefs="f0009">Fig. 9</figref> illustrates the areas of application and analysis of the samples HA, PD and PDC for the cells growth experiments on mice. The external analysis of the samples does not reveal any fibrotic reaction or inflammation process.</li></ul></p></description><claims mxw-id="PCLM56976849" lang="EN" load-source="patent-office"><!-- EPO <DP n="9"> --><claim id="c-en-0001" num="0001"><claim-text>A scaffold for the growth of tissue in vivo in the absence of cells formed by a matrix of interconnected growth surfaces spaced at regular intervals equal or larger than 0.7 mm and smaller than 3.0 mm.</claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>A scaffold according to claim 1 wherein the scaffold is formed by a matrix of interconnected growth surfaces spaced at regular intervals around a central support.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>A scaffold according to claim 1 wherein the interconnected growth surfaces are defined by the interconnection of multiple fibers or three-dimensional structures.</claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>A scaffold according to anyone of the preceding claims wherein the interconnected growth surfaces are spaced at regular intervals equal or larger than 0.9 mm and smaller than 3.0 mm.</claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>A scaffold according to anyone of the preceding claims wherein the interconnected growth surfaces are spaced at regular intervals equal or larger than 1.0 mm and smaller than 3.0 mm.</claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>A scaffold according to anyone of the preceding claims wherein the interconnected growth surfaces are spaced at regular intervals equal or larger than 1.0 mm and smaller than 2.0 mm.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>The use of a scaffold according to anyone of the preceding claims for the tissue reconstruction in vivo.</claim-text></claim></claims><drawings mxw-id="PDW16667620" load-source="patent-office"><!-- EPO <DP n="10"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="151" he="141" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="11"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="151" he="141" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="12"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="165" he="169" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="13"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="165" he="169" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="14"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="165" he="189" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="15"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="165" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="16"> --><figure id="f0007" num="7"><img id="if0007" file="imgf0007.tif" wi="165" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="17"> --><figure id="f0008" num="8"><img id="if0008" file="imgf0008.tif" wi="165" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="18"> --><figure id="f0009" num="9"><img id="if0009" file="imgf0009.tif" wi="165" he="199" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="158" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="159" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
